Pioglitazone Improved Insulin Sensitivity and First Phase Insulin Secretion Among Obese and Lean People with Diabetes: A Multicenter Clamp Study

Apoptosis in pancreatic β-islet cells in Type 2 diabetes

(2016) Tatsuo Tomita   Bosnian Journal of Basic Medical Sciences

Insulin Signaling and Heart Failure

(2016) Christian Riehle et al.   CIRCULATION RESEARCH

Quantification of adipose tissue insulin sensitivity

(2016) Esben Søndergaard et al.   JOURNAL OF INVESTIGATIVE MEDICINE

The Comparative Effect of Pioglitazone and Metformin on Serum Osteoprotegerin, Adiponectin and Intercellular Adhesion Molecule Concentrations in Patients with Newly Diagnosed Type 2 Diabetes: a Randomized Clinical Trial

(2015) A. Esteghamati et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective

(2015) Francesco Zaccardi et al.   POSTGRADUATE MEDICAL JOURNAL

Obesity, Insulin Resistance, and Incident Small Vessel Disease on Magnetic Resonance Imaging

(2015) Jennifer L. Dearborn et al.   STROKE

Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States

(2013) Ronald C.W. Ma et al.   Annals of the New York Academy of Sciences

Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium

(2013) Y. Chen et al.   BMJ-British Medical Journal

Three-month treatment with pioglitazone reduces circulating levels of thiobarbituric acid-reacting substances, a marker of reactive oxidative stress, without change in body mass index, in Japanese patients with type 2 diabetes

(2010) Hideaki Nakatsuji et al.   ATHEROSCLEROSIS

Diabetes in Asia

(2009) Ambady Ramachandran et al.   LANCET